Literature DB >> 15808754

Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction.

Jorik R Timmer1, Jan Paul Ottervanger, Menko-Jan de Boer, Jan-Henk E Dambrink, Jan C A Hoorntje, A T Marcel Gosselink, Harry Suryapranata, Felix Zijlstra, Arnoud W J van 't Hof.   

Abstract

OBJECTIVES: This study was designed to investigate whether elevated glucose is associated with impaired Thrombolysis In Myocardial Infarction (TIMI) flow before primary percutaneous coronary intervention (PCI).
BACKGROUND: Reperfusion before primary PCI in patients with ST-segment elevation myocardial infarction (STEMI) is associated with an improved outcome. Hyperglycemia in patients with STEMI is associated with an adverse prognosis. Hyperglycemia may induce a pro-thrombotic state and therefore be of influence on TIMI flow before PCI.
METHODS: A total of 460 consecutive patients with STEMI treated with primary PCI were included in this analysis. Hyperglycemia was defined as a glucose > or =7.8 mmol/l (140 mg/dl).
RESULTS: Hyperglycemia was observed in 70% and TIMI flow grade 3 before primary PCI in 17% of the patients. Patients with hyperglycemia less often had TIMI flow grade 3 before primary PCI (12% vs. 28%, p < 0.001). After adjustment for differences in baseline variables, hyperglycemia was a strong predictor of absence of reperfusion before primary PCI (odds ratio 2.6, 95% confidence interval 1.5 to 4.5).
CONCLUSIONS: Hyperglycemia in patients with STEMI is an important predictor of impaired epicardial flow before reperfusion therapy has been initiated. Investigation of methods improving coronary flow before primary PCI in these patients is warranted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15808754     DOI: 10.1016/j.jacc.2004.12.050

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  23 in total

1.  Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction.

Authors:  Artur Dziewierz; Dawid Giszterowicz; Zbigniew Siudak; Tomasz Rakowski; Jacek S Dubiel; Dariusz Dudek
Journal:  Clin Res Cardiol       Date:  2010-05-11       Impact factor: 5.460

2.  Association between Glycosylated Haemoglobin Level and Contrast-Induced Acute Kidney Injury in Patients with Type 2 Diabetes Mellitus.

Authors:  Sukru Akyuz; Tugba Kemaloglu Oz; Servet Altay; Mehmet Karaca; Baris Yaylak; Baris Gungor; Selcuk Yazici; Guney Erdogan; Zekeriya Nurkalem; Hulya Kasikcioglu
Journal:  Cardiorenal Med       Date:  2014-05-06       Impact factor: 2.041

3.  Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 study.

Authors:  Z Kadri; N Danchin; L Vaur; Y Cottin; P Guéret; M Zeller; J-M Lablanche; D Blanchard; G Hanania; N Genès; J-P Cambou
Journal:  Heart       Date:  2005-12-09       Impact factor: 5.994

Review 4.  [Diabetes mellitus and coronary artery disease--a high risk combination].

Authors:  V Schächinger; M B Britten; A M Zeiher
Journal:  Clin Res Cardiol       Date:  2006-01       Impact factor: 5.460

5.  Benefits of pharmacological facilitation with glycoprotein IIb-IIIa inhibitors in diabetic patients undergoing primary angioplasty for STEMI. A subanalysis of the EGYPT cooperation.

Authors:  Giuseppe De Luca; C Michael Gibson; Francesco Bellandi; Sabina Murphy; Mauro Maioli; Marko Noc; Uwe Zeymer; Dariusz Dudek; Hans-Richard Arntz; Simona Zorman; H Mesquita Gabriel; Ayse Emre; Donald Cutlip; Tomasz Rakowski; Mariann Gyongyosi; Kurt Huber; Arnoud W J Van't Hof
Journal:  J Thromb Thrombolysis       Date:  2008-11-22       Impact factor: 2.300

6.  The value of admission glycosylated hemoglobin level in patients with acute myocardial infarction.

Authors:  Mahmut Cakmak; Nazmiye Cakmak; Sebnem Cetemen; Halil Tanriverdi; Yavuz Enc; Onder Teskin; I Dogu Kilic
Journal:  Can J Cardiol       Date:  2008-05       Impact factor: 5.223

7.  In patients with acute myocardial infarction, the impact of hyperglycemia as a risk factor for mortality is not homogeneous across age-groups.

Authors:  José Carlos Nicolau; Carlos Vicente Serrano; Roberto Rocha Giraldez; Luciano Moreira Baracioli; Humberto Graner Moreira; Felipe Lima; Marcelo Franken; Roberto Kalil; José Antonio Franchini Ramires; Robert P Giugliano
Journal:  Diabetes Care       Date:  2011-10-25       Impact factor: 19.112

8.  BNP and admission glucose as in-hospital mortality predictors in non-ST elevation myocardial infarction.

Authors:  Julio Yoshio Takada; Rogério Bicudo Ramos; Solange Desiree Avakian; Soane Mota dos Santos; José Antonio Franchini Ramires; Antonio de Pádua Mansur
Journal:  ScientificWorldJournal       Date:  2012-02-01

9.  Impact of Acute Insulin Resistance on Myocardial Blush in Non-Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Soheir M Kasem; Ghada Mohamed Saied; Abdel Nasser Ma Hegazy; Mahmoud Abdelsabour
Journal:  Front Cardiovasc Med       Date:  2021-05-10

10.  Admission hyperglycemia and acute myocardial infarction: outcomes and potential therapies for diabetics and nondiabetics.

Authors:  Anjan K Chakrabarti; Priyamvada Singh; Lakshmi Gopalakrishnan; Varun Kumar; Meagan Elizabeth Doherty; Cassandra Abueg; Weici Wang; C Michael Gibson
Journal:  Cardiol Res Pract       Date:  2012-07-09       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.